<!doctype html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width,initial-scale=1" />
  <title>Ageing, immune fitness and cancer - Nature</title>
  <meta name="description" content="Ageing, immune fitness and cancer - Nature">
  <link rel="preconnect" href="https://fonts.googleapis.com">
  <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
  <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;600;800&family=DM+Serif+Display:ital@0;1&display=swap" rel="stylesheet">
  <link rel="stylesheet" href="../style.css" />
</head>
<body class="theme-darkblue">
  <header class="site-header">
    <div class="container row between middle">
      <a class="brand" href="../index.html" aria-label="Search 433">
        <svg class="logo-svg" viewBox="0 0 160 40" width="160" height="40" aria-hidden="true">
          <defs>
            <linearGradient id="g433" x1="0" y1="0" x2="1" y2="1">
              <stop offset="0%" stop-color="#7fb2ff"/>
              <stop offset="100%" stop-color="#2f6fff"/>
            </linearGradient>
          </defs>
          <rect x="0" y="0" rx="10" ry="10" width="52" height="40" fill="url(#g433)"></rect>
          <text x="26" y="26" text-anchor="middle" font-family="Inter, Arial" font-size="18" font-weight="800" fill="#fff">433</text>
          <text x="64" y="26" font-family="DM Serif Display, serif" font-size="20" fill="#e9f0ff"><tspan font-style="italic">Search</tspan> 433</text>
        </svg>
      </a>
      <nav class="nav">
        <a href="../index.html" class="nav-link">Home</a>
        <a href="./index.html" class="nav-link">Articles</a>
      </nav>
    </div>
  </header>

  <main>
    <div class="hero" style="background-image:url('../assets/gain-of-function-research-scp33ld7ive.jpg')"></div>
    <article class="prose container">
      <h1 class="article-title">Ageing, immune fitness and cancer - Nature</h1>
      <p class="byline">Published 2025-08-14 11:02 UTC</p>

      <h2>Ageing, Immune Fitness, and Cancer: A Shocking Revelation in the World of Gain-of-Function Research</h2>

<p>In a groundbreaking review published on August 14, 2025, researchers Melissa Dolan, Kendra A. Libby, Alison E. Ringel, Peter van Galen, and Sandra S. McAllister have unveiled a startling connection between aging, immune fitness, and cancer that could change the way we approach treatment for millions of patients worldwide. This research, appearing in the prestigious Nature Reviews Cancer, exposes the shocking reality that our immune systems undergo drastic transformations as we age, posing significant implications for cancer therapies.</p>

<p>The crux of the research suggests that the ability to combat infections, pathogens, and even malignancies diminishes with age, reshaping our antitumor immunity. This decline in immune fitness not only affects how our bodies respond to cancer but also calls into question the effectiveness of current immunotherapies. As the authors note, “age-associated changes in immune fitness reshape antitumour immunity and influence the efficacy of immunotherapies.”</p>

<blockquote>“Together, these perspectives provide a framework for integrating age as a critical biological variable,” the authors state.</blockquote>

<p>But wait—this isn’t just about the elderly being more susceptible to cancer. The implications are far more sinister. The research indicates that age-related changes in immune cell composition and function can alter cancer progression, making it imperative for clinical trials to account for age as a critical factor. Yet shockingly, older adults remain underrepresented in cancer trials, as highlighted by VanderWalde et al. in their 2022 study published in the Journal of Geriatric Oncology. According to their analysis, older adults face significant disparities in accrual to cancer trials, which could lead to skewed results and ineffective treatments for this vulnerable population.</p>

<p>The statistics are alarming: the American Cancer Society's 2024 report indicates that cancer remains a leading cause of death among those aged 65 and older. With the global population rapidly aging, this issue is more pressing than ever. The statistics reveal that 60% of cancer patients are over the age of 65—a demographic that is all too often neglected in clinical research. In fact, O’Rourke’s 2022 article in Cancer underscores the urgent need for the FDA to revise guidelines to include more older adults in cancer trials.</p>

<h2>The Shocking Truth Behind Immune Ageing</h2>

<p>So, what exactly is happening to our immune systems as we age? The review by Dolan and her colleagues delves into the “ageing haematopoiesis,” which affects the immune cells contributing to the tumor microenvironment. This means that as we grow older, the very cells that are supposed to protect us from cancer become less effective, leading to potentially catastrophic outcomes. This revelation raises a critical question: Are we doing enough to understand how our bodies’ defenses deteriorate over time?</p>

<blockquote>“Emerging evidence suggests that age-associated changes in immune fitness reshape antitumour immunity,” the researchers emphasize.</blockquote>

<p>In a world where gain-of-function research is often met with skepticism and criticism, this study reveals the pressing need to address the challenges posed by an aging population. The authors call for a paradigm shift in research and clinical practices, stating that “age-stratified analyses of treatment responses” are essential for developing effective cancer therapies. If we fail to heed this warning, we may be dooming countless patients to ineffective treatments simply because their age was not considered in the research.</p>

<h2>Unveiling the Future of Cancer Treatment</h2>

<p>As the field of cancer research evolves, it is critical that we embrace the complexity of cancer as a systemic disease. Swanton et al. (2024) argue in their research published in Cell that understanding cancer's multifaceted nature is essential for developing effective therapies. This means that age should no longer be viewed as a mere number but rather as a critical biological variable that shapes our immune response and, consequently, our cancer treatment outcomes.</p>

<p>Moreover, the implications of this research extend beyond the lab. The societal and ethical responsibilities of ensuring equitable access to cancer therapies for older adults cannot be overstated. With the alarming rates of cancer among the elderly, it is high time that healthcare systems reevaluate their approach to treatment and research. </p>

<blockquote>“The ageing immune system: is it ever too old to become young again?” the researchers provocatively ask.</blockquote>

<p>In conclusion, as we stand on the precipice of a new era in cancer research, the revelations from Dolan and her colleagues serve as a wake-up call. With an aging population and rising cancer rates, the urgency for age-inclusive research is more critical than ever. If we ignore the implications of this study, we risk perpetuating a cycle of ineffective treatments that disproportionately affect our older citizens. The time for change is now; let us not allow age to dictate the efficacy of our fight against cancer.</p>

      
      <section class="sources">
        <h2 class="sources-title">Sources</h2>
        <div class="sources-grid">
          
            <div class="source-card">
              <div class="source-meta">
                <div class="source-host">news.google.com</div>
              </div>
              <a class="btn btn-source" href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9tb2owdDVtZnF0ODkzS0JGSE5UQkNybzNvS0h6alNMakZxbG96OERzR3NTajJRZU11aUZMN1BxZFlLWmNEVjlmQjFGYnJGeVpodF94a3RIZkVHeU81VzBz?oc=5" target="_blank" rel="noopener">
                View source
              </a>
            </div>
          
        </div>
      </section>
      
    </article>
  </main>

  <footer class="site-footer">
    <div class="container row between wrap">
      <p>© <script>document.write(new Date().getFullYear())</script> Search 433</p>
      <p class="muted">Permanent archive.</p>
    </div>
  </footer>
</body>
</html>